A11S (p.Ala11Ser) variant of APP (Amyloid-beta precursor protein)
A11S (p.Ala11Ser) in APP (Amyloid-beta precursor protein) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data and structural context.
A11S (p.Ala11Ser) variant details
- p.Ala11Ser
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.34
- REVEL 0.21
- CADD 20.40
- PolyPhen-2 0.02
- SIFT 0.52
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available